RxDoctor Payments Data

Tara Prisco

Medical · Clark, NJNPI 1508017534

Payments from drug & device makers

$4,533in general payments, 2019–2025

Across 263 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$1K
  • Novo Nordisk$401
  • GSK$380
  • Boehringer Ingelheim$269
  • Abbott$180
  • plus $991 from 17 others

What the payments were for

  • Food & beverage$4,533100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,533 in reported general payments places this provider in the 85th percentile of 573 medical providers in New Jersey.

See all medical providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol62$65,148
Trelegy ElliptaFluticasone/Umeclidin/Vilanter59$52,019
EliquisApixaban46$43,584
JardianceEmpagliflozin44$42,709
OzempicSemaglutide25$28,090
RybelsusSemaglutide22$26,611
XareltoRivaroxaban22$22,801
JanuviaSitagliptin Phosphate36$22,674
TradjentaLinagliptin19$19,791
VraylarCariprazine Hcl11$15,512
JanumetSitagliptin Phos/Metformin Hcl17$15,311
EntrestoSacubitril/Valsartan20$13,830
MyrbetriqMirabegron15$13,189
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$12,799
Breo ElliptaFluticasone/Vilanterol24$12,657

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$1,021$77,94779 claims
GSKTrelegy Ellipta, Breo Ellipta$380$64,67683 claims
Boehringer IngelheimJardiance, Tradjenta$269$62,50063 claims
Novo NordiskOzempic, Rybelsus$401$54,70047 claims
PfizerEliquis$33$43,58446 claims
MerckJanuvia, Janumet$50$37,98553 claims
AbbVieVraylar, Synthroid$1,290$17,07858 claims
NovartisEntresto$99$13,83020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 573 medical providers in New Jersey.

Other medical in Clark

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →